1. Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;
2. Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD;
3. Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;
4. Moores Cancer Center, University of California, San Diego;
5. Department of Epidemiology, University of Texas M. D. Anderson Cancer Center, Houston;
6. Medical Research Council (MRC) Toxicology Unit, Leicester University, Leicester, United Kingdom;
7. Division of Hematology, Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy;
8. Flow and Image Cytometry Section, Divisions of Cell and Gene Therapies, Center for Biologics Research and Evaluation, Food and Drug Administration, Bethesda, MD;
9. Department of Medicine, Sydney University, Nepean Hospital, Penrith, Australia;
10. Kettering General Hospital, Kettering, United Kingdom;
11. Division of Hematology/Oncology, Moores Cancer Center, University of California, San Diego;
12. Division of Hematology, University of Texas M. D. Anderson Cancer Center, Houston;
13. Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN;
14. Section of Haemato-Oncology, Institute of Cancer Research, Sutton, United Kingdom